EIM
ISEE

Essex Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Essex Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-29,389
Closed -$1.36M – 384
2016
Q3 		$1.36M Sell
29,389
-523
-2% -$29.5K 0.22% 113
2016
Q2 		$1.53M Buy
29,912
+14,912
+99% +$741K 0.25% 100
2016
Q1 		$634K Hold
15,000
– – 0.11% 191
2015
Q4 		$1.18M Buy
15,000
+5,000
+50% +$289K 0.18% 132
2015
Q3 		$405K Buy
+10,000
New +$530K 0.07% 246

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Essex Investment Management's ISEE Position: Q4 2016 in Review

Essex Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 29,389 shares — an estimated $1.36M sold.

Essex Investment Management first reported a position in ISEE in Q3 2015 and held it in 5 quarters. The position peaked at $1.53M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Essex Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Essex Investment Management sold 29,389 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $1.36M.
  • Essex Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
  • Essex Investment Management's IVERIC bio, Inc. Common Stock position peaked at $1.53M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.